Detalhe da pesquisa
1.
Expression profiling of single cells and patient cohorts identifies multiple immunosuppressive pathways and an altered NK cell phenotype in glioblastoma.
Clin Exp Immunol
; 200(1): 33-44, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31784984
2.
Oncolytic vaccinia virus as a vector for therapeutic sodium iodide symporter gene therapy in prostate cancer.
Gene Ther
; 23(4): 357-68, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26814609
3.
Controlled infection with a therapeutic virus defines the activation kinetics of human natural killer cells in vivo.
Clin Exp Immunol
; 180(1): 98-107, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25469725
4.
Lymphokine-activated killer and dendritic cell carriage enhances oncolytic reovirus therapy for ovarian cancer by overcoming antibody neutralization in ascites.
Int J Cancer
; 134(5): 1091-101, 2014 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23982804
5.
Viral warfare! Front-line defence and arming the immune system against cancer using oncolytic vaccinia and other viruses.
Surgeon
; 12(4): 210-20, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24502935
6.
Measles virus causes immunogenic cell death in human melanoma.
Gene Ther
; 20(1): 7-15, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22170342
7.
Synergistic cytotoxicity of oncolytic reovirus in combination with cisplatin-paclitaxel doublet chemotherapy.
Gene Ther
; 20(5): 521-8, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22895509
8.
Enhancing the immunogenicity of tumour lysate-loaded dendritic cell vaccines by conjugation to virus-like particles.
Br J Cancer
; 106(1): 92-8, 2012 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-22134504
9.
Combination of a fusogenic glycoprotein, pro-drug activation and oncolytic HSV as an intravesical therapy for superficial bladder cancer.
Br J Cancer
; 106(3): 496-507, 2012 Jan 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-22240799
10.
OX40 and 4-1BB delineate distinct immune profiles in sarcoma.
Oncoimmunology
; 11(1): 2066050, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35558159
11.
Immune activation by combination human lymphokine-activated killer and dendritic cell therapy.
Br J Cancer
; 105(6): 787-95, 2011 Sep 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-21847125
12.
Dendritic cells and T cells deliver oncolytic reovirus for tumour killing despite pre-existing anti-viral immunity.
Gene Ther
; 16(5): 689-99, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19282847
13.
Microvascular free tissue transfer for gene delivery: in vivo evaluation of different routes of plasmid and adenoviral delivery.
Gene Ther
; 16(1): 78-92, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-18784747
14.
Escherichia coli nitroreductase plus CB1954 enhances the effect of radiotherapy in vitro and in vivo.
Gene Ther
; 15(6): 424-33, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18079753
15.
Inflammatory tumour cell killing by oncolytic reovirus for the treatment of melanoma.
Gene Ther
; 15(18): 1257-70, 2008 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-18401435
16.
Characterization of the adaptive and innate immune response to intravenous oncolytic reovirus (Dearing type 3) during a phase I clinical trial.
Gene Ther
; 15(12): 911-20, 2008 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18323793
17.
The immune system--is it relevant to cancer development, progression and treatment?
Clin Oncol (R Coll Radiol)
; 20(2): 101-12, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18037277
18.
Macrophages orchestrate the immune response to tumor cell death.
Cancer Res
; 61(19): 7240-7, 2001 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-11585761
19.
Looking a Gift Horse in the Mouth: Observations on NHS England's Interim Guidance on Pembrolizumab in Head and Neck Squamous Cell Cancer.
Clin Oncol (R Coll Radiol)
; 32(8): 490-492, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32513517
20.
Oncolytic reovirus enhances rituximab-mediated antibody-dependent cellular cytotoxicity against chronic lymphocytic leukaemia.
Leukemia
; 29(9): 1799-810, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25814029